A systematic review on the management of ductal carcinoma in situ of the breast

被引:0
作者
Brackstone, Muriel [1 ]
Durocher-Allen, Lisa [2 ]
Koch, C. Anne [3 ]
Califaretti, Nadia [4 ]
Eisen, Andrea [5 ]
Knowles, Sarah [6 ]
Plexman, Taude [7 ]
Salim, Abeer [7 ]
机构
[1] Victoria Hosp, London Hlth Sci Ctr, London Reg Canc Program, 800 Commisionners Rd East, London, ON N6A 5W9, Canada
[2] Ontario Hlth Canc Care Ontario, Program Evidence Based Care, 699 Concess St, Hamilton, ON L8V 1C3, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G2M9, Canada
[4] Grand River Reg Canc Ctr, 835 King St W, Kitchener, ON N2G 1G3, Canada
[5] Sunnybrook Odette Canc Ctr, Med Oncol, T2-038-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[6] St Josephs Hlth Care Ctr, Dept Surg, Dept Oncol, 268 Grosvenor St, London, ON N6A 4V2, Canada
[7] Ontario Hlth, 500-525 Univ Ave, Toronto, ON M5G 2L3, Canada
来源
SURGICAL ONCOLOGY-OXFORD | 2025年 / 60卷
关键词
SURGICAL ADJUVANT BREAST; CONSERVING TREATMENT; RANDOMIZED-TRIAL; POSTMENOPAUSAL WOMEN; SECTOR RESECTION; LOCAL RECURRENCE; DOUBLE-BLIND; RADIOTHERAPY; CANCER; TAMOXIFEN;
D O I
10.1016/j.suronc.2025.102223; 10.1016/j.suronc.2025.102223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页数:18
相关论文
共 45 条
[1]   Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor-Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24 [J].
Allred, D. Craig ;
Anderson, Stewart J. ;
Paik, Soonmyung ;
Wickerham, D. Lawrence ;
Nagtegaal, Iris D. ;
Swain, Sandra M. ;
Mamounas, Elefetherios P. ;
Julian, Thomas B. ;
Geyer, Charles E., Jr. ;
Costantino, Joseph P. ;
Land, Stephanie R. ;
Wolmark, Norman .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :1268-1273
[2]   Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-Year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J].
Bijker, Nina ;
Meijnen, Philip ;
Peterse, Johannes L. ;
Bogaerts, Jan ;
Van Hoorebeeck, Irene ;
Julien, Jean-Pierre ;
Gennaro, Massimiliano ;
Rouanet, Philippe ;
Avril, Antoine ;
Fentiman, Ian S. ;
Bartelink, Harry ;
Rutgers, Emiel J. Th. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3381-3387
[3]   Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ [J].
Bourgier, Celine ;
Cowen, Didier ;
Castan, Florence ;
Lemanski, Claire ;
Gourgou, Sophie ;
Rivera, Sofia ;
Labib, Alain ;
Peignaux, Karine ;
Le Blanc-Onfroy, Magali ;
Benyoucef, Ahmed ;
Mege, Alice ;
Douadi-Gaci, Zineb ;
Racadot, Severine ;
Latorzeff, Igor ;
Schick, Ulrike ;
Jacquot, Stephane ;
Massabeau, Carole ;
Guilbert, Philippe ;
Geffrelot, Julien ;
Ellis, Stephen ;
Lecouillard, Isabelle ;
Breton-Callu, Christel ;
Richard-Tallet, Agnes ;
Boulbair, Fatiha ;
Cretin, Jacques ;
Belkacemi, Yazid ;
Bons, Francoise ;
Azria, David ;
Fenoglietto, Pascal .
RADIOTHERAPY AND ONCOLOGY, 2021, 164 :57-65
[4]   Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial [J].
Brunt, Adrian Murray ;
Haviland, Joanne S. ;
Wheatley, Duncan A. ;
Sydenham, Mark A. ;
Alhasso, Abdulla ;
Bloomfield, David J. ;
Chan, Charlie ;
Churn, Mark ;
Cleator, Susan ;
Coles, Charlotte E. ;
Goodman, Andrew ;
Harnett, Adrian ;
Hopwood, Penelope ;
Kirby, Anna M. ;
Kirwan, Cliona C. ;
Morris, Carolyn ;
Nabi, Zohal ;
Sawyer, Elinor ;
Somaiah, Navita ;
Stones, Liba ;
Syndikus, Isabel ;
Bliss, Judith M. ;
Yarnold, John R. .
LANCET, 2020, 395 (10237) :1613-1626
[5]   Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study [J].
Chua, Boon H. ;
Link, Emma K. ;
Kunkler, Ian H. ;
Whelan, Timothy J. ;
Westenberg, A. Helen ;
Gruber, Guenther ;
Bryant, Guy ;
Ahern, Verity ;
Purohit, Kash ;
Graham, Peter H. ;
Akra, Mohamed ;
McArdle, Orla ;
O'Brien, Peter ;
Harvey, Jennifer A. ;
Kirkove, Carine ;
Maduro, John H. ;
Campbell, Ian D. ;
Delaney, Geoff P. ;
Martin, Joseph D. ;
Vu, T. Trinh T. ;
Muanza, Thierry M. ;
Neal, Anthony ;
Olivotto, Ivo A. .
LANCET, 2022, 400 (10350) :431-440
[6]   Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [J].
Cuzick, Jack ;
Sestak, Ivana ;
Pinder, Sarah E. ;
Ellis, Ian O. ;
Forsyth, Sharon ;
Bundred, Nigel J. ;
Forbes, John F. ;
Bishop, Hugh ;
Fentiman, Ian S. ;
George, William D. .
LANCET ONCOLOGY, 2011, 12 (01) :21-29
[7]   Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial [J].
Donker, Mila ;
Litiere, Saskia ;
Werutsky, Gustavo ;
Julien, Jean-Pierre ;
Fentiman, Ian S. ;
Agresti, Roberto ;
Rouanet, Philippe ;
de lara, Christine Tunon ;
Bartelink, Harry ;
Duez, Nicole ;
Rutgers, Emiel J. T. ;
Bijker, Nina .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4054-4059
[8]   SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening [J].
Emdin, Stefan O. ;
Granstrand, Bengt ;
Ringberg, Anita ;
Sandelin, Kerstin ;
Arnesson, Lars-Gunnar ;
Nordgren, Hans ;
Anderson, Harald ;
Garmo, Hans ;
Holmberg, Lars ;
Wallgren, Arne .
ACTA ONCOLOGICA, 2006, 45 (05) :536-543
[9]   Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [J].
Fisher, B ;
Dignam, J ;
Wolmark, N ;
Wickerham, DL ;
Fisher, ER ;
Mamounas, E ;
Smith, R ;
Begovic, M ;
Dimitrov, NV ;
Margolese, RG ;
Kardinal, CG ;
Kavanah, MT ;
Fehrenbacher, L ;
Oishi, RH .
LANCET, 1999, 353 (9169) :1993-2000
[10]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685